Cargando…

Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness

Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the evolution of symptoms in the first month of illness. At our institution, we conducted remote (telephone and video) visits for all adult outpatients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Janis E., Gotimukul, Ashwini, Wang, Fangfang, Mina, Syeda A., Bartels, Helen C., Burns, Mark W., Kole, Amy E., Vikram, Holenarasipur R., Gea-Banacloche, Juan C., Seville, M. Teresa, Petty, Skye A. Buckner, Vikram, Avinash, Orenstein, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213280/
https://www.ncbi.nlm.nih.gov/pubmed/34128896
http://dx.doi.org/10.1097/MD.0000000000026371
_version_ 1783709811645349888
author Blair, Janis E.
Gotimukul, Ashwini
Wang, Fangfang
Mina, Syeda A.
Bartels, Helen C.
Burns, Mark W.
Kole, Amy E.
Vikram, Holenarasipur R.
Gea-Banacloche, Juan C.
Seville, M. Teresa
Petty, Skye A. Buckner
Vikram, Avinash
Orenstein, Robert
author_facet Blair, Janis E.
Gotimukul, Ashwini
Wang, Fangfang
Mina, Syeda A.
Bartels, Helen C.
Burns, Mark W.
Kole, Amy E.
Vikram, Holenarasipur R.
Gea-Banacloche, Juan C.
Seville, M. Teresa
Petty, Skye A. Buckner
Vikram, Avinash
Orenstein, Robert
author_sort Blair, Janis E.
collection PubMed
description Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the evolution of symptoms in the first month of illness. At our institution, we conducted remote (telephone and video) visits for all adult outpatients diagnosed with COVID-19 within 24 h of a positive nasopharyngeal polymerase chain test for SARS-CoV-2. We repeated regular video visits at 7, 14, and 28 days after the positive test, retrospectively reviewed the prospective data collected in the remote visits, and constructed a week by week profile of clinical illness, through week 4 of illness. We reviewed the courses of 458 symptomatic patients diagnosed between March 12, 2020, and June 22, 2020, and characterized their weekly courses. Common initial symptoms included fever, headache, cough, and chest pain, which frequently persisted through week 3 or longer. Upper respiratory or gastrointestinal symptoms were much shorter lived, present primarily in week 1. Anosmia/ageusia peaked in weeks 2 to 3. Emergency department visits were frequent, with 128 visits in the 423 patients who were not hospitalized and 48 visits among the 35 outpatients (7.6%) who were eventually hospitalized (2 subsequently died). By the fourth week, 28.9% said their illness had completely resolved. After the 4-week follow up, 20 (4.7%) of the 423 nonhospitalized patients had further medical evaluation and management for subacute or chronic COVID-19 symptoms. Mild to moderate outpatient COVID-19 is a prolonged illness, with evolving symptoms commonly lasting into the fourth week of illness.
format Online
Article
Text
id pubmed-8213280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82132802021-06-21 Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness Blair, Janis E. Gotimukul, Ashwini Wang, Fangfang Mina, Syeda A. Bartels, Helen C. Burns, Mark W. Kole, Amy E. Vikram, Holenarasipur R. Gea-Banacloche, Juan C. Seville, M. Teresa Petty, Skye A. Buckner Vikram, Avinash Orenstein, Robert Medicine (Baltimore) 4900 Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the evolution of symptoms in the first month of illness. At our institution, we conducted remote (telephone and video) visits for all adult outpatients diagnosed with COVID-19 within 24 h of a positive nasopharyngeal polymerase chain test for SARS-CoV-2. We repeated regular video visits at 7, 14, and 28 days after the positive test, retrospectively reviewed the prospective data collected in the remote visits, and constructed a week by week profile of clinical illness, through week 4 of illness. We reviewed the courses of 458 symptomatic patients diagnosed between March 12, 2020, and June 22, 2020, and characterized their weekly courses. Common initial symptoms included fever, headache, cough, and chest pain, which frequently persisted through week 3 or longer. Upper respiratory or gastrointestinal symptoms were much shorter lived, present primarily in week 1. Anosmia/ageusia peaked in weeks 2 to 3. Emergency department visits were frequent, with 128 visits in the 423 patients who were not hospitalized and 48 visits among the 35 outpatients (7.6%) who were eventually hospitalized (2 subsequently died). By the fourth week, 28.9% said their illness had completely resolved. After the 4-week follow up, 20 (4.7%) of the 423 nonhospitalized patients had further medical evaluation and management for subacute or chronic COVID-19 symptoms. Mild to moderate outpatient COVID-19 is a prolonged illness, with evolving symptoms commonly lasting into the fourth week of illness. Lippincott Williams & Wilkins 2021-06-18 /pmc/articles/PMC8213280/ /pubmed/34128896 http://dx.doi.org/10.1097/MD.0000000000026371 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4900
Blair, Janis E.
Gotimukul, Ashwini
Wang, Fangfang
Mina, Syeda A.
Bartels, Helen C.
Burns, Mark W.
Kole, Amy E.
Vikram, Holenarasipur R.
Gea-Banacloche, Juan C.
Seville, M. Teresa
Petty, Skye A. Buckner
Vikram, Avinash
Orenstein, Robert
Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title_full Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title_fullStr Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title_full_unstemmed Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title_short Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
title_sort mild to moderate covid-19 illness in adult outpatients: characteristics, symptoms, and outcomes in the first 4 weeks of illness
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213280/
https://www.ncbi.nlm.nih.gov/pubmed/34128896
http://dx.doi.org/10.1097/MD.0000000000026371
work_keys_str_mv AT blairjanise mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT gotimukulashwini mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT wangfangfang mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT minasyedaa mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT bartelshelenc mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT burnsmarkw mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT koleamye mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT vikramholenarasipurr mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT geabanaclochejuanc mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT sevillemteresa mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT pettyskyeabuckner mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT vikramavinash mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness
AT orensteinrobert mildtomoderatecovid19illnessinadultoutpatientscharacteristicssymptomsandoutcomesinthefirst4weeksofillness